Supreme Court: Suo Motu Case on SMA Treatment Gaps, Moots Dedicated Fund

The Supreme Court of India recently initiated a suo motu writ petition to address the significant treatment gaps faced by patients suffering from Spinal Muscular Atrophy (SMA) and has mooted the creation of a dedicated corpus for their financial support.

This proactive step by a Bench comprising Chief Justice of India Surya Kant and Justices Joymalya Bagchi and V. Mohana, titled “In Re: Lack of Adequate and Systematic Treatment for SMA Patients and Other Ancillary Issues,” highlights the Court's concern over the inadequate and systematic financial support hindering both preventive and post-atrophy treatment for SMA patients. The Court's intervention stemmed from proceedings related to online content demeaning persons with disabilities, including those with SMA. Senior Advocate Aparajita Singh, representing the Cure SMA Foundation of India, had previously suggested the establishment of such a corpus by the Union Government, a suggestion the Court found appropriate. The Court indicated that if an existing fund is in place, it should be widely publicized to encourage contributions from corporate entities and individuals, including through Corporate Social Responsibility (CSR) initiatives, and noted that further judicial intervention might be required on the proposal.

The legal significance of this suo motu action is substantial, as it demonstrates the Supreme Court's commitment to public health and the rights of persons with disabilities, particularly those affected by rare diseases. This initiative could pave the way for significant policy reforms and the establishment of robust funding mechanisms for SMA treatment, potentially setting a precedent for other rare genetic disorders. It underscores the judiciary's role in compelling governmental action to ensure access to essential healthcare and social welfare for vulnerable populations.

The legal context for this development lies in the Supreme Court's exercise of its extraordinary suo motu writ jurisdiction, typically invoked under Articles 32 or 142 of the Constitution of India, to address matters of grave public importance. This power allows the Court to take cognizance of issues without a formal petition, acting as a guardian of fundamental rights and social justice. The discussion around a dedicated corpus implicates the state's constitutional obligations regarding public health and social security, as well as the potential for leveraging corporate social responsibility for public good. The key parties involved are the Supreme Court of India, particularly the Bench led by CJI Surya Kant, and the Cure SMA Foundation of India, represented by Senior Advocate Aparajita Singh, with the Union Government being the implied entity for establishing and managing the proposed corpus.

Practising attorneys involved in public interest litigation, healthcare law, or disability rights should closely monitor the progress of this suo motu proceeding. The eventual directions or rulings from the Supreme Court could establish critical precedents regarding state funding for rare disease treatments, the scope of healthcare access as a fundamental right, and the role of CSR in national health initiatives. Businesses, especially those with active CSR programs, should be aware of potential opportunities or expectations to contribute to such a corpus if it is formally established, as this could become a significant area of corporate engagement.